Table 2. Main baseline characteristics of the men with non remittent asthma and with remittent asthma at follow-up and adjusted Odds Ratios^* (CI95%) for the effects of these variables reported at baseline on asthma remission at follow-up.

	Non remittent asthma	Remittent asthma	Unadjusted p-value	Adjusted OR* (CI95%)
	n = 68	n = 28
Age at baseline (years), mean(sd)	33.4 (7.8)	33.2 (6.9)	0.893	0.95 (0.88,1.02)
Smoking habits (%)£			0.772
Non smoker	42.6	46.4		1.00
Ex-smoker	20.6	14.3		1.18 (0.15;9.25)
Current smoker	36.8	39.3		0.85 (0.22;3.25)
Age at onset of asthma (years), median	10	10	0.842	1.02 (0.96;1.08)
Age at onset of asthma (years), (IQR) §	(6–16)	(5–20)
ICS use in the last 3 mo. at baseline (%)	43.9	11.1	0.002	0.36 (0.08;1.58)
Asthma control at baseline (%) ‡			<0.001
Total control	23.5	75.0		1.00
Partial control	53.0	21.4		0.16 (0.07;0.62)
No control	23.5	3.6		0.06 (0.01;0.33)
Allergic rhinitis (%)	82.4	71.4	0.231	0.56 (0.11;2.91)

^*Also adjusted for the type of interview (telephone vs face to face).

£ Overall adjusted p-value for smoking  = 0.5896.

^§IQR, Interquartile Range: (1^st quartile–3^rd quartile).

^‡Overall adjusted p-value for asthma control at baseline <0.0001.

Significant unadjusted p-value and adjusted OR (p<0.05) are reported in bold.